VGT-1849A

N/A

Report date: 2025/02/18 16:56:12
NME

Base Information

Drug NameVGT-1849A
Drug Alias NameVGT-1849A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK2
Therapy Area/IndicationsPolycythemia Vera
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVanda Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesVanda Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPolycythemia Vera
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A